abrdn Healthcare Investors (abrdn Healthcare Investors) EV-to-Revenue

: 13.42 (As of Today)

View and export this data going back to . Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, abrdn Healthcare Investors's enterprise value is $780.19 Mil. abrdn Healthcare Investors's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $58.12 Mil. Therefore, abrdn Healthcare Investors's EV-to-Revenue for today is 13.42.

The historical rank and industry rank for abrdn Healthcare Investors's EV-to-Revenue or its related term are showing as below:

HQH' s EV-to-Revenue Range Over the Past 10 Years
Min: -6.34 Med: 5.48 Max: 15.48
Current: 13.42

During the past 7 years, the highest EV-to-Revenue of abrdn Healthcare Investors was 15.48. The lowest was -6.34. And the median was 5.48.

HQH's EV-to-Revenue is ranked worse than
63% of 1438 companies
in the Asset Management industry
Industry Median: 9.215 vs HQH: 13.42

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-18), abrdn Healthcare Investors's stock price is $15.78. abrdn Healthcare Investors's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $1.24. Therefore, abrdn Healthcare Investors's PS Ratio for today is 12.71.

abrdn Healthcare Investors EV-to-Revenue Historical Data

The historical data trend for abrdn Healthcare Investors's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Healthcare Investors Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EV-to-Revenue

-5.46

3.72

7.39

-4.26

13.23

abrdn Healthcare Investors Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-Revenue									7.39	-	-4.26	-	13.23

Competitive Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

abrdn Healthcare Investors EV-to-Revenue Distribution

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's EV-to-Revenue falls into.

abrdn Healthcare Investors EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

abrdn Healthcare Investors's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	780.191	/	58.118
	=	13.42

abrdn Healthcare Investors's current Enterprise Value is $780.19 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. abrdn Healthcare Investors's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was $58.12 Mil.

abrdn Healthcare Investors (NYSE:HQH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

abrdn Healthcare Investors's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	15.78	/	1.242
	=	12.71

abrdn Healthcare Investors's share price for today is $15.78.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Sep. 2023 was $1.24.

abrdn Healthcare Investors EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of abrdn Healthcare Investors's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

abrdn Healthcare Investors (abrdn Healthcare Investors) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Healthcare Investors (NYSE:HQH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

900 Market Street, Suite 200, Philadelphia, PA, USA, 19103

Website

https://www.teklacap.com

abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Executives

Todd Reit	director	C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher	director	600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Alan R Goodson	officer: Vice President	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Rose Dimartino	director	C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor	other: Director of Adviser	C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze	other: Director of Adviser	C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc.	other: Adviser	1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick	other: Director of Adviser	C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar	officer: VP and Chief Legal Officer	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols	other: Director of Adviser	1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard	officer: President	ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy	officer: Secretary and Vice President	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari	officer: Treasurer and CFO	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina	officer: Chief Compliance Officer & VP	1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird	director	388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022